Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	74.31	-2.64	-10.28
Graham Fair Price	-4.94	22.74	23.92
PEG	366.03	-0.52	0.11
Price/Book	31.98	0.45	0.34
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	16.51	5.16	4.43
Price/Sales	-55.26	1.70	3.80
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-95.51	< 0.005	0.22
ROA	-1.50	< 0.005	< 0.005
ROE	0.02	0.02	13.28
ROIC	< 0.005	< 0.005	-98.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.12	0.15	-23.68
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.14	-1.12	-703.15
EPS QOQ	0.40	-0.10	-75.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	-0.07	1.59	2191.36
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	1057.57	8.50	-99.20
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.66	0.66	0.21
Quick Ratio	3.04	3.49	14.89
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	36.43	32.53	-10.68
Cash	104.26	96.57	-7.38
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	3.25	8.57	163.50
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.04	5.58	83.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-27.59	169.92	515.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating